Denmark· DK-28106236619
Isotretinoin "Sandoz"
A isotretinoin product containing isotretinoin, registered in Denmark by Sandoz A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Isotretinoin is registered in 13 of 19 countries.
Countries holding a registration under ATC D10BA01 (isotretinoin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Isotretinoin · ATC D10BA01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of isotretinoin costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $1.27 in Italy to $2.18 in Switzerland — a ×1.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Isotretinoin · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.18
- IT Italy$1.27
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Isotretinoin
- Manufacturer
- Sandoz A/S
- Country
- Denmark (DK)
- ATC code
- D10BA01
- ATC class
- Isotretinoin
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106236619
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
127 interactions on record for isotretinoin.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isotretinoin · interactions on record
127 records
- 21 severe
- 96 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- AcitretinD05BB02severe
- DemeclocyclineJ01AA01severe
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under D10BA01
Isotretinoin, as other registers publish it.
- CanadaABSORICA LDSUN PHARMACEUTICAL INDUSTRIES LIMITED
- CanadaABSORICA LDSUN PHARMACEUTICAL INDUSTRIES LIMITED
- CanadaABSORICA LDSUN PHARMACEUTICAL INDUSTRIES LIMITED
- CanadaABSORICA LDSUN PHARMACEUTICAL INDUSTRIES LIMITED
- CanadaACCUTANE ROCHEHOFFMANN-LA ROCHE LIMITED
- CanadaACCUTANE ROCHEHOFFMANN-LA ROCHE LIMITED
- DenmarkAcnenorTeva B.V.
- DenmarkAcnenorTeva B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcf7d48a-db33-4d80-a676-6c237752d178 GET /v1/drugs/bcf7d48a-db33-4d80-a676-6c237752d178?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "kapsler, bløde",
"source": "dkma",
"strength": "20 mg",
"auth_role": "CMS",
"dk_drugid": "28106236619",
"substance": "Isotretinoin",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "43978"
}See everything about isotretinoin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.